Neurotrope, Inc., a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (AD), announced that Dr. Charles Ryan, CEO, will be a featured presenter at the LD Micro Invitational Conference on Tuesday, June 4, 2019 at 9:40 AM Pacific Time at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
May 30, 2019
· 3 min read